Chidamide-based 3-drug combination regimen reverses molecular relapse post transplantation in AML1-ETO–positive acute myeloid leukemia

Chidamide-based 3-drug combination regimen reverses molecular relapse post transplantation in AML1-ETO–positive acute myeloid leukemia

Objective: We aimed to explore a new method to reverse early relapse in patients with AML1-ETO–positive acute myeloid cell transplantation.Methods: A chidamide-based 3-drug combination regimen was used in our center to treat patients with AML1-ETO–positive AML post transplantation but negative flow...

Full description

Bibliographic Details
Main Authors: Yang Xi, Li Chenglong, Zhang Rong, Wang Wen, Wang Yu, Chen Jiao, Huang Juan, Che Feifei, Xiao Rong, Jiang Tao, Li Hui, Huang Xiaobing
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Pharmacology
Subjects:
chidamide
3-drug combination
AML1-ETO
post-transplantation
relapse
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.1059930/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.1059930/full

Similar Items